Alamar Biosciences, Inc. (ALMR)
Healthcare • Medical Devices
StockNasdaqGSUnited StatesUS0109111056
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Alamar Biosciences, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:32. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 18 Feb 2027 16:00 | -0.24 | — | — | Upcoming |
| 03 Nov 2026 16:00 | -0.19 | -0.19 | -1.7% | Miss |
| 10 Aug 2026 16:00 | -0.32 | -0.20 | +37.4% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 74.2M | +195.2% | -29.8M | -40.2% | -0.45 | +36.7% | -60M |
| 2024 | 25.1M | — | -47.1M | -187.2% | -0.71 | — | -58.6M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 28.64 | 32.50 | 28.39 | 29.96 | +6.81% | 2,419,136 | |
| 02 Nov 2026 – 06 Nov 2026 | 30.88 | 30.88 | 25.31 | 28.05 | -8.33% | 4,854,500 | |
| 26 Oct 2026 – 30 Oct 2026 | 30.65 | 35.33 | 29.36 | 30.60 | -0.29% | 3,487,300 | |
| 19 Oct 2026 – 23 Oct 2026 | 25.38 | 31.51 | 25.28 | 30.69 | +21.40% | 3,796,700 | |
| 12 Oct 2026 – 16 Oct 2026 | 25.07 | 28.35 | 22.98 | 25.28 | +0.04% | 3,967,000 | |
| 05 Oct 2026 – 09 Oct 2026 | 34.66 | 39.61 | 24.23 | 25.27 | -26.46% | 5,358,100 | |
| 28 Sep 2026 – 02 Oct 2026 | 32.71 | 35.28 | 31.94 | 34.36 | +4.76% | 2,775,900 | |
| 21 Sep 2026 – 25 Sep 2026 | 35.20 | 35.66 | 31.68 | 32.80 | -5.88% | 2,247,100 | |
| 14 Sep 2026 – 18 Sep 2026 | 27.89 | 37.76 | 27.25 | 34.85 | +24.96% | 3,910,800 | |
| 08 Sep 2026 – 11 Sep 2026 | 30.49 | 30.91 | 27.33 | 27.89 | -9.45% | 1,071,300 | |
| 21 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Alamar Biosciences, Inc. (ALMR) Presents at 2026 UBS Global Healthcare Conference Transcript (opens in a new tab) SeekingAlpha · 10 Nov 2026 19:31
- Why Is GSK (LSE:GSK) Drawing Attention For New Cancer Data And Proteomics? (opens in a new tab) Simply Wall St. · 09 Nov 2026 19:15
- Alamar Biosciences: Recurring Revenue Potential At A High Premium (opens in a new tab) SeekingAlpha · 09 Nov 2026 08:15
- Does Alamar Biosciences (ALMR) Sit Above Fair Value After The Selloff? (opens in a new tab) Simply Wall St. · 05 Nov 2026 13:13
- Alamar Biosciences to Participate in Upcoming Investor Conferences (opens in a new tab) 04 Nov 2026 21:05
- Alamar Biosciences (ALMR) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 04 Nov 2026 16:32
- TD Cowen Maintains Buy on Alamar Biosciences, Raises Price Target to $36 (opens in a new tab) Benzinga · 04 Nov 2026 15:06
- Alamar Biosciences (ALMR) Could Be 15% Undervalued On Q3 Results And Guidance (opens in a new tab) Simply Wall St. · 04 Nov 2026 08:12
- Alamar Biosciences Inc (ALMR) (Q3 2026) Earnings Call Highlights: Revenue Jumps 68% as Guidance ... (opens in a new tab) GuruFocus.com · 04 Nov 2026 05:10
- Alamar Biosciences Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 04 Nov 2026 00:14
- Alamar (ALMR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (opens in a new tab) Zacks · 03 Nov 2026 22:00
- Alamar Biosciences, Inc. (ALMR) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 03 Nov 2026 21:45
- Alamar: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 03 Nov 2026 21:16
- Alamar Biosciences Reports Third Quarter 2026 Financial Results and Raises 2026 Revenue Guidance (opens in a new tab) 03 Nov 2026 21:05
- Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine (opens in a new tab) 03 Nov 2026 21:03
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 31.76 USD
- Market cap
- 2.2B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Devices
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow ALMR and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.